Neonatal liver physiology

Seminars in Pediatric Surgery

Volumn 22, Issue 4, 2013, Pages 185-189

  Grijalva, James ^a   Vakili, Khashayar ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Bile synthesis; Biotransformation; Fatty acid; Glucose; Liver; Metabolism; Neonatal; Physiologic jaundice; Physiology

Indexed keywords

BILE ACID; BILIRUBIN; BLOOD CLOTTING FACTOR; CHENODEOXYCHOLIC ACID; CHOLESTEROL; CHOLIC ACID; CYTOCHROME P450; FATTY ACID; GLUCAGON; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); XENOBIOTIC AGENT;

AEROBIC METABOLISM; ARTICLE; BILE ACID SYNTHESIS; BILIRUBIN METABOLISM; BIOTRANSFORMATION; BLOOD OXYGENATION; CELL DIFFERENTIATION; CELL MATURATION; CENTRAL VEIN; CIRCULATION; DUCTUS VENOSUS; EMBRYO DEVELOPMENT; ENDODERM; ENTEROHEPATIC CIRCULATION; ENZYME ACTIVITY; EPITHELIUM CELL; FATTY ACID METABOLISM; FETUS CIRCULATION; FETUS LIVER; GALLBLADDER; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; HEPATOBILIARY SYSTEM; INSULIN BLOOD LEVEL; INTRAHEPATIC BILE DUCT; LIVER CELL; LIVER CLEARANCE; LIVER DEVELOPMENT; LIVER FUNCTION; LIVER STRUCTURE; LIVER VEIN; MESENCHYME CELL; NEONATAL LIVER FUNCTION; NEWBORN PERIOD; NUTRIENT SUPPLY; PATENT FORAMEN OVALE; PREMATURITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; UMBILICAL VEIN;

BILE SYNTHESIS; BIOTRANSFORMATION; FATTY ACID; GLUCOSE; LIVER; METABOLISM; NEONATAL; PHYSIOLOGIC JAUNDICE; PHYSIOLOGY;

BIOTRANSFORMATION; HUMANS; INFANT, NEWBORN; LIVER; LIVER CIRCULATION; ORGANOGENESIS;

EID: 84890032592     PISSN: 10558586     EISSN: 15329453     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2013.10.006     Document Type: Article

References (74)

1. Diehl-Jones W.L., Askin D.F. The neonatal liver. Part 1: embryology, anatomy and physiology. Neonatal Netw 2002, 21(2):5-12.
2. Shiojiri N. Development and differentiation of bile ducts in the mammalian liver. Microsc Res Tech 1997, 39(4):328-335.
3. Zaret K.S. Hepatocyte differentiation: from the endoderm and beyond. Curr Opin Genet Dev 2001, 11(5):568-574.
4. Duncan S.A. Mechanisms controlling early development of the liver. Mech Dev 2003, 120(1):19-33.
5. Rossi J.M., Dunn N.R., Hogan B.L., Zaret K.S. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Geves Dev 2001, 15:1998-2009.
6. Houssaint E. Differentiation of the mouse hepatic primordium. I. An analysis of tissue interactions in hepatocyte differentiation. Cell Differ 1980, 9:269.
7. Amenta P.S., Harrison D. Expression and potential role of the extracellular matrix in hepatic ontogenesis: a review. Microsc Res Tech 1997, 39:372.
8. Shah K.D., Gerber M.A. Development of intrahepatic bile ducts in humans. Possible role of laminin. Arch Pathol Lab Med 1990, 114:597.
9. Terada T., Nakanuma Y. Expression of tenascin, type IV collagen and lamin during human intrahepatic bile duct development and intrahepatic cholangiocarcinoma. Histopathology 1994, 25:143.
10. Rudolph A.M. Hepatic and ductus venosus blood flows during fetal life. Hepatology 1983, 3:254.
11. Nagano K., Hoshino H., Nishimura D., Katada N., Sano H., Kato K. Patent ductus venosus. J Gastroenterol Hepatol 1999, 14(3):285-288.
12. Haugen G., Hanson M., Kiserud T., Crozier S., Inskip H., Godfrey K.M. Fetal liver-sparing cardiovascular adaptations linked to mother's slimness and diet. Circ Res 2005, 96(1):12-14.
13. Edelstone D.I. Regulation of blood flow through the ductus venosus. J Dev Physiol 1980, 2(4):219.
14. Behrman R.E., Lees M.H., Peterson E.N., De Lannoy C.W., Seeds A.E. Distribution of the circulation in the normal and asphyxiated fetal primate. Am J Obstet Gynecol 1970, 108(6):956-969.
15. Kondo M., Itoh S., Kunikata T., et al. Time of closure of ductus venosus in term and preterm neonates. Arch Dis Child Fetal Neonatal Ed 2001, 85(1):F57-F59.
16. Loberant N., Herskovits M., Barak M., et al. Closure of the ductus venosus in premature infants: findings on real-time gray-scale, color-flow doppler, and duplex doppler sonography. Am J Roentgenol 1999, 172(1):227-229.
17. Pineiro-Carrero V., Pineiro E. Liver. Pediatrics 2004, 113(4):1097-1106.
18. Tanaka T., Watanabe J., Asaka Y., Ogawa R., Kanamura S. Quantitative analysis of endoplasmic reticulum and cytochrome P-450 in hepatocytes from rats injected with methylcholanthrene. Eur J Cell Biol 1997, 74(1):20-30.
19. Aggarwal S.R., Lindros K.O., Palmer T.N. Glucagon stimulates phosphorylation of different peptides in isolated periportal and perivenous hepatocytes. FEBS Lett 1995, 377(3):439-443.
20. McCashland R.M., Tuma D.J., Sorrell M.R., Casey C.A. Zonal differences in ethanol-induced impairments in hepatic receptor binding. Alcohol 1993, 10(6):549-554.
21. Lawrence G.M., Trayer I.P., Walker D.G. Histochemical and immunohistochemical localization of hexokinase isoenzymes in normal rat liver. Histochem J 1984, 16(10):1099-1111.
22. +-dependent dehydrogenases in the limiting plate and the residual parenchyma surrounding terminal hepatic venules. Histochemistry 1984, 80(1):91-95.
23. Beath S.V. Hepatic function and physiology in the newborn. Semin Neonatol 2003, 8:337-346.
24. Platt M.W., Deshpande S. Metabolic adaptation at birth. Semin Fetal Neonatal Med 2005, 10:341-350.
25. 2] glucose tracers. J Clin Endocrinol Metab 1980, 50(3):456-460.
26. Heck L.J., Erenberg A. Serum glucose levels in term neonates during the first 48 hours of life. J Pediatr 1987, 110(1):119-122.
27. Srinivasan G., Pildes R.S., Cattamanchi G., Voora S., Lillien L.D. Plasma glucose values in normal neonates: a new look. J Pediatr 1986, 109(1):114-117.
28. Bloom S.R., Johnston D.I. Failure of glucagon release in infants of diabetic mothers. Br Med J 1972, 4(5838):453-454.
29. Sperling M.A., DeLamater P.V., Phelps D., Fiser R.H., Oh W., Fisher D.A. Spontaneous and amino acid stimulated glucagon secretion in the immediate post-natal period: relation to glucose and insulin. J Clin Invest 1974, 53(4):1159-1166.
30. Shelley H.J. Glycogen reserves and their changes at birth and in anoxia. Br Med Bull 1961, 17:137-143.
31. 13C. J Clin Endocrinol Metab 1976, 43(3):704-707.
32. Bier D.M., Leake R.D., Haymond M.W., et al. Measurement of 'true' glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 1977, 26(11):1016-1023.
33. Burchell A., Gibb L., Waddell I.D., Giles M., Hume R. The ontogeny of the human hepatic glucose-6-phosphatase proteins. Clin Chem 1990, 36(9):1633-1637.
34. Herrera E., Amusquivar E. Lipid metabolism in the fetus and newborn. Diabetes Metab Res Rev 2000, 16(3):202-210.
35. Marcus C., Ehren H., Bolme P., Arner P. Regulation of lipolysis during the neonatal period: importance of thyrotropin. J Clin Invest 1988, 82(5):1793-1797.
36. Girard J.R., Cuendet G.S., Marliss E.B., Kervran A., Rieutort M., Assan R. Fuels, hormones and liver metabolism at term and during the early postnatal period in the rat. J Clin Invest 1973, 52(12):3190-3200.
37. Issad T., Coupe C., Ferre P., Girard J. Insulin resistance during suckling period in rats. Am J Physiol 1987, 253(2, Pt 1):E142-E148.
38. Bougneres P.F., Lemmel P., Ferre P., Bier D.M. Ketone body transport in the human neonate and infant. J Clin Invest 1986, 77(1):42-48.
39. Hawdon J., Ward Platt M., Aynsley-Green A. Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch Dis Child 1992, 67(4 Spec No):357-365.
40. Shelley H.J. Glycogen reserves and their changes at birth. Br Med Bull 1975, 3:137-143.
41. Hume R., Burchell A. Abnormal expression of glucose-6-phosphatase in preterm infants. Arch Dis Child 1993, 68(2):202-204.
42. Jackson L., Burchell A., McGeechan A., Hume R. An inadequate glycaemic response to glucagon is linked to insulin resistance in preterm infants?. Arch Dis Child 2003, 88(1):F62-F66.
43. Greengard O., Dewey H.K. Initiation by glucagon of the premature development of tyrosine aminotransferase, serine dehydratase, and glucose-6-phosphatase in fetal rat liver. J Biol Chem 1967, 242(12):2986-2991.
44. Deshpande S., Hawdon J.M., Ward Platt M.P., Aynsley-Green A. Metabolic adaptation to extrauterine life. Fetal Medicine: Basic Science and Clinical Practice 1999, 1059-1069. Churchill Livingstone, London. C.H. Rodeck, M.J. Whittle (Eds.).
45. Watchko J.F., Lin Z. Exploring the genetic architecture of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med 2010, 15(3):169-175.
46. Dennery P.A., Seidman D.S., Stevenson D.K. Neonatal hyperbilirubinemia. N Engl J Med 2001, 344(8):581-590.
47. Watchko J.F., Maisels M.J. Jaundice in low birth weight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed 2003, 88(6):F455-F458.
48. Raju T.N.K. Developmental physiology of late and moderate prematurity. Semin Fetal Neonatal Med 2012, 17(3):126-131.
49. Lester, St Pyrek J., Little J.M., Adcock E.W. Diversity of bile acids in the fetus and newborn infant. J Pediatr Gastroenterol Nutr 1983, 2(2):355-364.
50. Setchell K.D., Dumaswala R., Colombo C., Ronchi M. Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile. J Biol Chem 1988, 263(32):16637-16644.
51. Gustafsson J. Bile acid biosynthesis during development: hydroxylation of C-27 sterols in human fetal liver. J Lipid Res 1986, 27(8):801-806.
52. Little J.M., Richey J.E., Van Thiel D.H., Lester R. Taurocholate pool size and distribution in the fetal rat. J Clin Invest 1979, 63(5):1042-1049.
53. Subbiah M.T., Hassan A.S. Development of bile acid biogenesis and its significance in cholesterol homeostasis. Adv Lipid Res 1982, 19:137-161.
54. Heubi J.E., Balistreri W.F., Suchy F.J. Bile salt metabolism in the first year of life. J Lab Clin Med 1982, 100(1):127-136.
55. Shaffer E.A., Zahazi I., Gall D.G. Postnatal development of hepatic bile formation in the rabbit. Dig Dis Sci 1985, 30(6):558-563.
56. Henning S.J. Postnatal development: coordination of feeding, digestion, and metabolism. Am J Physiol 1981, 241(3):G199-G214.
57. Barnard J.A., Ghishan F.K., Wilson F.A. Ontogenesis of taurocholate transport by rat ileal brush border membrane vesicles. J Clin Invest 1985, 75(3):869-873.
58. Suchy F.J., Balistreri W.F., Heubi J.E., Searcy J.E., Levin R.S. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology 1981, 80(5 Pt 1):1037-1041.
59. Lester R. Physiologic cholestasis. Gastroenterology 1980, 78(4):864-865.
60. Balistreri W.F., Heubi J.E., Suchy F.J. Immaturity of the enterohepatic circulation in early life: factors predisposing to "physiologic" maldigestion and cholestasis. J Pediatr Gastroenterol Nutr 1983, 2(2):346-354.
61. Hardikar W., Ananthanarayanan M., Suchy F.J. Differential ontogenic regulation of basolateral and canalicular bile acid transport proteins in rat liver. J Biol Chem 1995, 270(35):20841-20846.
62. Heubi J.E., Balistreri W.F., Suchy F.J. Bile salt metabolism in the first year of life. J Lab Clin Med 1982, 100(1):127-136.
63. Ho M.L., Chen J.Y., Ling U.P., Su P.H. Gallbladder volume and contractility in term and preterm neonates: normal values and clinical applications in ultrasonography. Acta Paediatr 1998, 87(7):799-804.
64. Ricour C., Rey J. Study of the hydrolysis and micellar solubilazation of fats during intestinal perfusion. I. Results in the normal child. Rev Eur Etud Clin Biol 1972, 17(2):172-178.
65. Alcorn J., McNamara P.J. Ontogeny of hepatic and renal systemic clearance pathways in infants Part 1. Clin Pharacokinet 2002, 41(12):959-998.
66. Balistreri W.F. Immaturity of hepatic excretory function and the ontogeny of bile acid metabolism. J Pediatr Gastroenterol Nutr 1983, 2(suppl 1):S207-S214.
67. Treluyer J.M., Cheron G., Sonnier M., Cresteil T. Cytochrome P-450 expression in sudden infant death syndrome. Biochem Pharmacol 1996, 52(3):497-504.
68. Treluyer J.M., Gueret G., Cheron G., Sonnier M., Cresteil T. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility. Pharmacogenetics 1997, 7(6):441-452.
69. Nebert D.W. Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol Endocrinol 1991, 5(9):1203-1214.
70. Gilman J.T. Therapeutic drug monitoring in the neonate and paediatric age group: problems and clinical pharmacokinetic implications. Clin Pharmacokinet 1990, 19(1):1-10.
71. Sato Y. Pharmacokinetics of antibiotics in neonates. Acta Paediatr Jpn 1997, 39(1):124-131.
72. Krauer B., Dayer P. Fetal drug metabolism and its possible clinical implications. Clin Pharmacokinet 1991, 21(1):70-80.
73. Coughtrie M.W., Burchell B., Leakey J.E., Hume R. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 1988, 34(6):729-735.
74. Mikkelsen S., Feilberg V.L., Christensen C.B., Lundstrom K.E. Morphine pharmacokinetics in premature and mature newborn infants. Acta Paediatr 1994, 83(10):1025-1028.